Daniel Sem News Today

Estrigenix Therapeutics, Inc. is the recipient of a $300,000 National Institute of Health (NIH) Small Business Innovation Research (SBIR) grant.

MEQUON — Concordia University Wisconsin Dean of the Business School Daniel Sem has announced that he is leaving the position to become vice provost for Research and Innovation.

ONLINE: Wisconsin Innovation Network press release: From lab to marketplace: Learn how Milwaukee tech transfer works at Jan. 26 Tech Council webinar A growing commercial pathway for intellectual property in Wisconsin runs through research and development engines in the Milwaukee region, both private and public. Join “technology transfer” leaders from five of those entities for a webinar 10 a.m. Tuesday, Jan. 26. The webinar is hosted b...